Fennec Pharma board member Raykov retiring; board size reducing to five directors

Filed April 28, 2026 · Period ending April 27, 2026 · ~1 min read

Key Changes

• low

  Director Rostislav Raykov will not stand for re-election at the 2026 annual meeting, with his term expiring immediately after. The filing confirms his departure is not due to any disagreement with company operations or policies.

  Item 5.02 verify on EDGAR →
• low

  Board voted to reduce size from six to five directors effective after the annual meeting, aligning with Raykov's departure and leaving no vacancies. This is a routine governance adjustment.

  Item 5.02 verify on EDGAR →